Anesthetic management for ascending aorta replacement in a patient who refused autologous transfusion for religious reasons

J Anesth. 2009;23(3):436-8. doi: 10.1007/s00540-009-0764-1. Epub 2009 Aug 14.

Abstract

We report on the anesthetic management of a 69-year-old female Jehovah's Witness undergoing cardiopulmonary bypass to replace the ascending aorta; the patient refused transfusion of stored autologous or allogeneic blood products for religious reasons. The strategy involved preoperative hematopoiesis with recombinant human erythropoietin and iron, intraoperative acute normovolemic hemodilution, the use of a cell-saver system, administration of high-dose tranexamic acid, controlled hypotension, avoidance of low body temperature, simplification of the surgery, and lower blood dilution during cardiopulmonary bypass.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anesthesia, General
  • Angioplasty
  • Anticoagulants / therapeutic use
  • Antifibrinolytic Agents / therapeutic use
  • Aorta / surgery*
  • Blood Transfusion, Autologous*
  • Blood Volume
  • Cardiopulmonary Bypass
  • Erythropoietin / therapeutic use
  • Female
  • Hematopoiesis / drug effects
  • Hemodilution
  • Heparin / therapeutic use
  • Humans
  • Hypotension, Controlled
  • Jehovah's Witnesses*
  • Recombinant Proteins
  • Tranexamic Acid / therapeutic use
  • Treatment Refusal

Substances

  • Anticoagulants
  • Antifibrinolytic Agents
  • Recombinant Proteins
  • Erythropoietin
  • Tranexamic Acid
  • Heparin